(Q44295306)

1 December 2017

title

Dermatologic complications associated with administration of 2',3'-dideoxycytidine in patients with human immunodeficiency virus infection (English)

1 reference

1 December 2017

M C McNeely

1

1 reference

1 December 2017

R Yarchoan

series ordinal

2

1 reference

1 December 2017

S Broder

series ordinal

3

1 reference

1 December 2017

T J Lawley

series ordinal

4

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 December 1989

1 reference

Journal of the American Academy of Dermatology

1 December 2017

published in

1 reference

1 December 2017

volume

21

1 reference

1 December 2017

issue

6

1 reference

1 December 2017

page(s)

1213-1217

1 reference

Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970332-7

7 January 2021

An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970332-7

7 January 2021

Severe Acquired Immunodeficiency in Male Homosexuals, Manifested by Chronic Perianal Ulcerative Herpes Simplex Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970332-7

7 January 2021

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970332-7

7 January 2021

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970332-7

7 January 2021

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970332-7

7 January 2021

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970332-7

7 January 2021

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970332-7

7 January 2021

Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970332-7

7 January 2021

Nucleosides. IX. The Formation of 2',3'-Unsaturated Pyrimidine Nucleosides via a Novel β-Elimination Reaction1,2

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970332-7

7 January 2021

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970332-7

7 January 2021

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970332-7

7 January 2021

Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970332-7

7 January 2021

10.1016/S0190-9622(89)70332-7

Identifiers

DOI

1 reference

1 December 2017

1 reference